This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

StemCells, Inc. To Participate At 2013 Regen Med Investor Day In New York

NEWARK, Calif., April 15, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will present an update on the Company's programs and operations at the 2013 Regen Med Investor Day to be held on Wednesday, April 17, 2013, at the Harmonie Club, 4 East 60 th Street, New York, NY. Mr. McGlynn is scheduled to make his presentation at 4:00 pm EDT. In addition, Stephen Huhn, MD, FACS, FAAP, Vice President and Head of the CNS Program at StemCells, Inc., will participate in an expert panel discussion on "Therapeutics for a Broad Range of CNS Diseases," which is scheduled to begin at 11:05 am EDT. All the day's events, including Mr. McGlynn's presentation and Dr. Huhn's panel discussion, will be webcast live and available at .

The 2013 Regen Med Investor Day, which is organized by the Alliance for Regenerative Medicine (ARM) and co-hosted by leading financial firms Burrill & Company, Maxim Group and Piper Jaffray, is intended to provide institutional, strategic and venture investors unique insight into the investment thesis for regenerative medicine-based therapeutics and tools. The 2013 Regen Med Investor Day will begin with keynote talks by Jeff Jonas, President of Shire Regenerative Medicine and Kieran Murphy, President and CEO, GE Healthcare Life Sciences.  These will be followed by focused discussions among key opinion leaders, top investment analysts and senior company executives on three of the industry's more prominent target indications, including disorders of the central nervous system (CNS).  Company presentations, showcasing 16 leading, publicly traded small- and mid-cap companies in the field, will be in the afternoon. 

Attendance at this event is for credentialed investors and members of the media only. If you are interested in attending, please contact Laura Parsons at  More information is available at .

A replay of the webcast will be available on ARM's website shortly after the event.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs